New HIV Drug Lenacapavir Offers Up to Six Months Protection

'One injection protects up to six months': what is new HIV drug lenacapavir?

As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention, RFI spoke with infectious disease specialist Ndong Essomba Bitchoka about how the treatment works, whether the supply will meet demand and why developing an HIV vaccine remains a challenge.

By RFI